Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma

Kalibixiati Aimulajiang,Wen Chu,Shuyi Liao,Zhaohai Wen,Rongdong He,Mingmin Lu,Lixin Xu,Xiaokai Song,Xiangrui Li,Ruofeng Yan
DOI: https://doi.org/10.1002/iid3.1321
2024-06-20
Immunity Inflammation and Disease
Abstract:rTS‐Succinate Coenzyme A ligase beta (SUCLA‐β) can reduce the levels of eosinophils around bronchus and blood vessels and the number of inflammatory cells in bronchoalveolar lavage fluid. rTS‐SUCLA‐β could reduce the Immunoglobulin level of the mouse upon OVA sensitization/challenge. rTS‐SUCLA‐β treatment regulates host immunity by promoting Treg cells differentiation and inhibiting Th17 cells differentiation and plays an important role in allergic asthma. Background For decades, studies have demonstrated the anti‐inflammatory potential of proteins secreted by helminths in allergies and asthma. Previous studies have demonstrated the immunomodulatory capabilities of Succinate Coenzyme A ligase beta‐like protein (SUCLA‐β) derived from Trichinella spiralis, a crucial excretory product of this parasite. Objective To explore the therapeutic potential of SUCLA‐β in alleviating and controlling ovalbumin (OVA)‐induced allergic asthma, as well as its influence on host immune modulation. Methods In this research, we utilized the rTs‐SUCLA‐β protein derived from T. spiralis to investigate its potential in mitigating airway inflammation in a murine model of asthma induced by OVA sensitization/stimulation, both pre‐ and post‐challenge. The treatment's efficacy was assessed by quantifying the extent of inflammation in the lungs. Results Treatment with rTs‐SUCLA‐β demonstrated efficacy in ameliorating OVA‐induced airway inflammation, as evidenced by a reduction in eosinophil infiltration, levels of OVA‐specific Immunoglobulin E, interferon‐γ, interleukin (IL)‐9, and IL‐17A, along with an elevation in IL‐10. The equilibrium between Th17 and Treg cells plays a pivotal role in modulating the abundance of inflammatory cells within the organism, thereby ameliorating inflammation and alleviating symptoms associated with allergic asthma. Conclusions and Clinical Relevance Our data revealed that T. spiralis‐derived Ts‐SUCLA‐β protein may inhibit the allergic airway inflammation by regulating host immune responses.
immunology
What problem does this paper attempt to address?